ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31

Could an HPV test with extended genotyping that can individually identify HPV 16, 18, 31, and other genotypes change the way we manage cervical cancer screening results?

In this video, Dr. Mark Stoler, Professor of Pathology and Clinical Gynecology at the University of Virginia Health System, discusses the special case of HPV 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Cervical Cancer Screening: The Current State of Testing
Cervical Cancer | Articles & Publications
Cervical Cancer Screening: The Current State of Testing
physician and patient
New Harris Poll Finds Women Want More Education on Sexually Transmitted Infections Testing and Treatment
Fast Company op-ed
Cervical Cancer | News & Updates
POV: The U.S. healthcare system is failing Black and Latina women